MGIC Investment (MTG) Q4 Earnings Beat Estimates
zacks.com
ADMA Biologics, Inc.ADMANASDAQ
LOADING
|||
Alerts
Want to monitor ADMA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor ADMAWant to monitor ADMA?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor ADMAADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human - slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida.